erwise eligible for such program or through the use of 
vouchers to obtain such testing. 
(c) DEFINITIONS.—In this section: 
(1) COVERED
EVALUATION.—The term ‘‘cov-
ered evaluation’’ means— 
(A) a periodic health assessment conducted 
in accordance with section 2(a); 
(B) a separation history and physical ex-
amination conducted under section 1145(a)(5) 
of title 10, United States Code, as amended by 
section 2(b); and 
(C) a deployment assessment conducted 
under section 1074f(b)(2) of such title, as 
amended by section 2(c). 
(2) COVERED INDIVIDUAL.—The term ‘‘covered 
individual’’ means a former member of the Armed 
Forces or a family member of a member or former 
member of the Armed Forces who lived at a location 
(or the surrounding area of such a location) identi-
fied by the Department of Defense as a location 
with a known or suspected release of perfluoroalkyl 
substances or polyfluoroalkyl substances during the 
period in which the individual lived at that location 
(or surrounding area). 
VerDate Sep 11 2014 
19:43 Nov 05, 2020
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H8643.IH
H8643
pamtmann on DSKBC07HB2PROD with BILLS
(3) 
TRICARE 
PROGRAM.—The 
term 
‘‘TRICARE program’’ has the meaning given that 
term in section 1072(7) of title 10, United States 
Code. 
SEC. 
4. 
DOCUMENTATION 
OF 
EXPOSURE 
TO 
PERFLUOROALKYL 
SUBSTANCES 
OR 
POLYFLUOROALKYL SUBSTANCES. 
(a) SHARING OF INFORMATION.—The Secretary of 
Defense and the Secretary of Veterans Affairs shall enter 
into a memorandum of understanding providing for the 
sharing by the Department of Defense with the Depart-
ment of Veterans Affairs of the results of covered evalua-
tions regarding the exposure by a member of the Armed 
Forces to perfluoroalkyl substances or polyfluoroalkyl sub-
stances. 
(b) REGISTRY.— 
(1) ESTABLISHMENT.—The Secretary of De-
fense shall establish a registry of members of the 
Armed Forces who have been exposed to, or are sus-
pected to have been exposed to, perfluoroalkyl sub-
stances or polyfluoroalkyl substances. 
(2) INCLUSION
IN
REGISTRY.—The Secretary 
shall include a member of the Armed Forces in the 
registry established under paragraph (1) if a covered 
VerDate Sep 11 2014 
19:43 Nov 05, 2020
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H8643.IH
H8643
pamtmann on DSKBC07HB2PROD with BILLS
evaluation of the member establishes that the mem-
ber— 
(A) was based or stationed at a location 
identified by the Department of Defense as a 
location with a known or suspected release of 
perfluoroalkyl substances or polyfluoroalkyl sub-
stances during the period in which the member 
was based or stationed at the location; or 
(B) was exposed to such substances. 
(3) BLOOD TESTING.—The results of any blood 
test conducted under section 3(a) shall be included 
in the registry established under paragraph (1) for 
any member of the Armed Forces included in the 
registry. 
(4) ELECTION.—A member of the Armed 
Forces may elect not to be included in the registry 
established under paragraph (1). 
(c) PROVISION OF INFORMATION.—The Secretary of 
Defense shall provide to a member of the Armed Forces 
more information on perfluoroalkyl substances and 
polyfluoroalkyl substances and the potential impact of ex-
posure to such substances if a covered evaluation of such 
member establishes that the member— 
(1) was based or stationed at a location identi-
fied by the Department of Defense as a location 
VerDate Sep 11 2014 
19:43 Nov 05, 2020
Jkt 019200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H8643.IH
H8643
pamtmann on DSKBC07HB2PROD with BILLS
with a known or suspected release of perfluoroalkyl 
substances or polyfluoroalkyl substances during the 
period in which the member was based or stationed 
at the location; or 
(2) was exposed to such substances. 
(d) RULE OF CONSTRUCTION.—Nothing in this sec-
tion may be construed to preclude eligibility of a veteran 
for benefits under the laws administered by the Secretary 
of Veterans Affairs by reason of the exposure of the vet-
eran to perfluoroalkyl substances or polyfluoroalkyl sub-
stances not being recorded in a covered evaluation. 
(e) COVERED EVALUATION DEFINED.—In this sec-
tion, the term ‘‘covered evaluation’’ means— 
(1) a periodic health assessment conducted in 
accordance with section 2(a); 
(2) a separation history and physical examina-
tion conducted under section 1145(a)(5) of title 10, 
United States Code, as amended by section 2(b); 
and 
(3) a deployment assessment conducted under 
section 1074f(b)(2) of such title, as amended by sec-
tion 2(c). 
Æ 
VerDate Sep 11 2014 
19:43 Nov 05, 2020
Jkt 019200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H8643.IH
H8643
pamtmann on DSKBC07HB2PROD with BILLS